Cargando…
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
SIMPLE SUMMARY: About 30% of patients with papillary thyroid cancer (PTC) experience persistent/recurrent disease within 10 years after an initial treatment, serum thyroglobulin (Tg) representing the gold standard for surveillance. However, the measurement of serum Tg is unreliable in the presence o...
Autores principales: | Campennì, Alfredo, Aguennouz, M’hammed, Siracusa, Massimiliano, Alibrandi, Angela, Polito, Francesca, Oteri, Rosaria, Baldari, Sergio, Ruggeri, Rosaria Maddalena, Giovanella, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688692/ https://www.ncbi.nlm.nih.gov/pubmed/36428713 http://dx.doi.org/10.3390/cancers14225620 |
Ejemplares similares
-
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients
por: Campennì, Alfredo, et al.
Publicado: (2023) -
Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients
por: Campennì, Alfredo, et al.
Publicado: (2018) -
Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
por: Trovato, Maria, et al.
Publicado: (2017) -
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic
por: Ruggeri, Rosaria Maddalena, et al.
Publicado: (2020) -
The Influence of Food Regimes on Oxidative Stress: A Permutation-Based Approach Using the NPC Test
por: Zirilli, Agata, et al.
Publicado: (2023)